Record NNP B-NP O
date NN I-NP O
: : O O
2075-01-22 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
Intern NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
PATIENT NNP B-NP O
: : O O
ITO NNP B-NP I-PATIENT
, , O I-PATIENT
WENDY NNP B-NP I-PATIENT
MRN NNP B-NP O
: : O O
152 CD B-NP B-MEDICALRECORD
47 CD I-NP I-MEDICALRECORD
20 CD O I-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
1/21/2075 CD B-NP B-DATE
TIME NN I-NP O
: : O O
6pm NN B-NP O
ATTENDING NN B-NP O
: : O O
Dr NNP B-NP O
Gerry NNP I-NP B-DOCTOR
Baldwin NNP I-NP I-DOCTOR
and CC O O
Dr. NNP B-NP O
Grace NNP I-NP B-DOCTOR
Jewell NNP I-NP I-DOCTOR
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
Noah NNP I-NP B-DOCTOR
Quintin-Mcclure NNP I-NP I-DOCTOR
Poinciana NNP I-NP B-CITY
, , O O
030-624-6793 CD O B-PHONE
CONTACT NN B-NP O
: : O O
Verner NNP B-NP B-PATIENT
Ito NNP I-NP I-PATIENT
, , O O
( -LRB- B-NP I-PHONE
215)638-3640 CD I-NP I-PHONE
or CC I-NP O
( -LRB- I-NP I-PHONE
365)775-4811 CD I-NP I-PHONE
Son NN I-NP O
Gilberto NNP I-NP B-PATIENT
Ito NNP I-NP I-PATIENT
877-274-0509 CD I-NP B-PHONE
, , O O
Son NN B-NP O
Code NNP B-NP O
status NN I-NP O
: : O O
Full NNP B-NP O
Code NNP I-NP O
( -LRB- B-VP O
discussed VBN I-VP O
with IN B-PP O
patient NN B-NP O
and CC I-NP O
family NN I-NP O
) -RRB- O O
Source NN B-NP O
: : O O
Patient NNP B-NP O
, , O O
patient NN B-NP O
record NN I-NP O
CC NNP B-NP O
: : O O
HTN NNP B-NP O
and CC I-NP O
SOB NNP I-NP O
HPI NNP B-NP O
: : O O
Ms. NNP B-NP O
Iot NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
69 CD I-NP B-AGE
-year-old JJ I-NP O
female NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
CHF NNP B-NP O
( -LRB- O O
EF NNP B-NP O
40 CD I-NP O
% NN I-NP O
, , O O
no DT B-NP O
home NN I-NP O
O2 IN B-PP O
) -RRB- B-NP O
, , O O
DM NNP B-NP O
type NN I-NP O
2 CD B-NP O
, , O O
HTN NNP B-NP O
, , O O
nephrotic JJ B-NP O
syndrome NN I-NP O
, , O O
and CC O O
1/8 CD B-NP I-DATE
/2075 CD I-NP I-DATE
R NN I-NP O
humerus NN I-NP O
ORIF IN B-PP O
presenting VBG B-VP O
from IN B-PP O
Crest NNP B-NP B-HOSPITAL
Nursing NNP I-NP I-HOSPITAL
Home NNP I-NP I-HOSPITAL
with IN B-PP O
SOB NNP B-NP O
and CC I-NP O
HTN. NNP I-NP O
She PRP B-NP O
was VBD B-VP O
discharged VBN I-VP O
from IN B-PP O
NGH NNP B-NP B-HOSPITAL
to TO B-VP O
rehab VB I-VP O
on IN B-PP O
1/8 CD B-NP I-DATE
/2075 CD I-NP I-DATE
after IN B-PP O
ORIF NNP B-NP O
of IN B-PP O
a DT B-NP O
right JJ I-NP O
humeral JJ I-NP O
fracture NN I-NP O
. . O O
She PRP B-NP O
feels VBZ B-VP O
that IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
doing VBG I-VP O
fairly RB B-ADVP O
at IN B-PP O
rehab NN B-NP O
. . O O
On IN B-PP O
the DT B-NP O
evening NN I-NP O
prior RB B-ADVP O
to TO B-PP O
admission NN B-NP O
, , O O
however RB B-ADVP O
, , O O
she PRP B-NP O
had VBD B-VP O
some DT B-NP O
anxiety NN I-NP O
that IN B-SBAR O
resolved VBN B-VP O
after IN B-PP O
receiving VBG B-VP O
Ativan NNP B-NP O
from IN B-PP O
her PRP$ B-NP O
nurse NN I-NP O
. . O O
She PRP B-NP O
then RB B-ADVP O
was VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
fall VB I-VP O
asleep RB B-ADVP O
but CC I-ADVP O
woke-up RB I-ADVP O
at IN B-PP O
2AM NNP B-NP O
with IN B-PP O
diaphoresis NN B-NP O
and CC O O
SOB. NNP B-NP O
She PRP B-NP O
denied VBD B-VP O
chest NN B-NP O
pain NN I-NP O
. . O O
She PRP B-NP O
was VBD B-VP O
attended VBN I-VP O
to TO I-VP O
and CC I-VP O
her PRP$ B-NP O
BP NNP I-NP O
was VBD B-VP O
220/117 CD B-NP O
. . O O
She PRP B-NP O
was VBD B-VP O
given VBN I-VP O
2 CD B-NP O
SL NNP I-NP O
NTG NNP I-NP O
, , O O
O2 NNP B-NP O
, , O O
and CC O O
Lasix NNP B-NP O
, , O O
after IN B-PP O
which WDT B-NP O
her PRP$ B-NP O
SOB NNP I-NP O
somewhat RB B-ADVP O
improved VBD B-VP O
but CC O O
her PRP$ B-NP O
HTN NNP I-NP O
continued VBD B-VP O
. . O O
She PRP B-NP O
also RB B-ADVP O
complains VBZ B-VP O
of IN B-PP O
a DT B-NP O
chronic JJ I-NP O
cough NN I-NP O
that WDT B-NP O
is VBZ B-VP O
productive JJ B-ADJP O
of IN B-PP O
white/yellow NN B-NP O
sputum NN I-NP O
. . O O
She PRP B-NP O
denies VBZ B-VP O
missed VBN I-VP O
medications NNS B-NP O
, , O O
changes NNS B-NP O
in IN B-PP O
diet NN B-NP O
, , O O
adding VBG B-VP O
salt NN B-NP O
to TO B-PP O
meals NNS B-NP O
( -LRB- O O
although IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
at IN B-PP O
rehab NN B-NP O
and CC O O
her PRP$ B-NP O
diet NN I-NP O
order NN I-NP O
is VBZ B-VP O
unclear JJ B-ADJP O
) -RRB- O O
. . O O
At IN B-PP O
this DT B-NP O
time NN I-NP O
, , O O
she PRP B-NP O
denies VBZ B-VP O
CP CD B-NP O
, , O O
SOB. NNP B-NP O
ED VBN B-NP O
COURSE NNP I-NP O
: : O O
Vitals NNS B-NP O
upon IN B-PP O
arrival NN B-NP O
to TO B-PP O
the DT B-NP O
ED NNP I-NP O
were VBD B-VP O
T NNP B-NP O
98.9 CD I-NP O
HR NNP I-NP O
114 CD I-NP O
BP NNP I-NP O
225/125 CD I-NP O
RR NNP I-NP O
32 CD I-NP O
02 CD I-NP O
Sat NNP I-NP O
84 CD I-NP O
% NN I-NP O
RA. NNP I-NP O
Exam NNP I-NP O
was VBD B-VP O
notable JJ B-ADJP O
for IN B-PP O
tachycardia NN B-NP O
, , O O
rales NNS B-NP O
at IN B-PP O
the DT B-NP O
apices NNS I-NP O
, , O O
use NN B-NP O
of IN B-PP O
accessory JJ B-NP O
muscles NNS I-NP O
, , O O
and CC O O
LE JJ B-NP O
edema NN I-NP O
. . O O
Labs NNPS B-NP O
were VBD B-VP O
notable JJ B-ADJP O
for IN B-PP O
elevated JJ B-NP O
WBC NNP I-NP O
and CC I-NP O
BNP NNP I-NP O
, , O O
non-infected JJ B-NP O
U/A NNP I-NP O
, , O O
and CC O O
evidence NN B-NP O
of IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
on IN B-PP O
CXR NNP B-NP O
. . O O
She PRP B-NP O
received VBD B-VP O
Lasix NNP B-NP O
40mg CD I-NP O
IV NNP I-NP O
X2 NNP I-NP O
, , O O
nitoglycerin NN B-NP O
, , O O
Nitropaste,ASA NNP B-NP O
81mg CD I-NP O
, , O O
Metformin NNP B-NP O
500 CD I-NP O
, , O O
Simvastatin NNP B-NP O
40 CD I-NP O
, , O O
Losartan NNP B-NP O
50 CD I-NP O
, , O O
Lisinopril NNP B-NP O
40 CD I-NP O
, , O O
Prozac NNP B-NP O
20 CD I-NP O
, , O O
Calcium NNP B-NP O
carbonate NN I-NP O
, , O O
and CC O O
Lopressor NNP B-NP O
25 CD I-NP O
. . O O
She PRP B-NP O
produced VBD B-VP O
700 CD B-NP O
cc JJ I-NP O
urine NN I-NP O
. . O O
Upon IN B-PP O
d/c NN B-NP O
from IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
BP NNP B-NP O
was VBD B-VP O
157/72 CD B-NP O
and CC I-NP O
O2 NNP I-NP O
sat VBD B-VP O
was VBD B-VP O
100 CD B-NP O
% NN I-NP O
on IN B-PP O
2L. DT B-NP O
LENIs NNP I-NP O
were VBD B-VP O
pending VBG I-VP O
. . O O
ROS NNS B-NP O
General NNP B-NP O
: : O O
Positive JJ B-ADJP O
for IN B-PP O
diaphoresis NN B-NP O
and CC I-NP O
fatigue NN I-NP O
. . O O
no DT B-NP O
weight NN I-NP O
loss NN I-NP O
or CC I-NP O
gain NN I-NP O
; : O O
no DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
syncope NN B-NP O
HEENT NNP B-NP O
: : O O
no DT B-NP O
visual JJ I-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
hearing NN I-NP O
changes NNS I-NP O
; : O O
no DT B-NP O
neck NN I-NP O
pain NN I-NP O
Pulmonary NNP B-NP O
: : O O
no DT B-NP O
wheezing NN I-NP O
, , O O
no DT B-NP O
hemoptysis NN I-NP O
Cardiac NNP B-NP O
: : O O
Positive JJ B-ADJP O
for IN B-PP O
orthopnea NN B-NP O
. . O O
Uses '' O O
2 CD B-NP O
pillow NN I-NP O
. . O O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
palpitations NNS I-NP O
. . B-NP O
No NN I-NP O
PND. . O O
Gastrointestinal NNP B-NP O
: : O O
Positive JJ B-ADJP O
for IN B-PP O
constipation NN B-NP O
. . O O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG B-VP O
, , O O
diarrhea NN B-NP O
; : O O
no DT B-NP O
jaundice NN I-NP O
; : O O
no DT B-NP O
abd NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
GIB NN I-NP O
Genitourinary JJ B-NP O
: : O O
Positive JJ B-ADJP O
for IN B-PP O
inc NN B-NP O
urinary JJ I-NP O
freq NNS I-NP O
( -LRB- B-PP O
chronic NN B-NP O
) -RRB- O O
but CC O O
no DT B-NP O
dysuria NN I-NP O
, , O O
hesitancy NN B-NP O
, , O O
no DT B-NP O
incontinence NN I-NP O
; : O O
no DT B-NP O
hematuria NN I-NP O
Extremity NN B-NP O
: : O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
Neurology NNP B-NP O
: : O O
no DT B-NP O
HA NNP I-NP O
, , O O
no DT B-NP O
photophobia NN I-NP O
, , O O
no DT B-NP O
changes NNS I-NP O
in IN B-PP O
strength/sensation NN B-NP O
; : O O
no DT B-NP O
numbness NN I-NP O
or CC I-NP O
tingling NN I-NP O
; : O O
no DT B-NP O
seizure NN I-NP O
activity NN I-NP O
MEDICAL NNP B-NP O
HISTORY NN I-NP O
1 LS O O
. . B-NP O
Diabetes NNP I-NP O
mellitus NN I-NP O
type NN I-NP O
2 CD I-NP O
: : O O
Last JJ B-NP O
a1c NN I-NP O
was VBD B-VP O
7.90 CD B-NP O
( -LRB- I-NP O
10/2074 CD I-NP B-DATE
) -RRB- I-NP O
, , O O
Last JJ B-NP O
Urine NNP I-NP O
Microalb NNP I-NP O
283.0 CD I-NP O
( -LRB- I-NP O
10/2074 CD I-NP B-DATE
) -RRB- O O
- : O O
C/b NN B-NP O
renal JJ B-NP O
failure NN I-NP O
, , O O
h/o RB B-NP O
diabetic JJ I-NP O
foot NN I-NP O
ulcer NN I-NP O
2. . B-NP O
Hypertension NNP I-NP O
3. . B-NP O
Hyperlipidemia NNP I-NP O
4 CD B-LST O
. . O O
Ischemic NNP B-NP O
CMP NNP I-NP O
-- : O O
TTE NNP B-NP O
( -LRB- I-NP O
3/74 NN I-NP B-DATE
) -RRB- I-NP O
showed VBD B-VP O
EF NNP B-NP O
40 CD I-NP O
% NN I-NP O
, , O O
LV NNP B-NP O
wall NN I-NP O
dysfunction NN I-NP O
-- : B-NP O
Adenosine NNP I-NP O
MIBI NNP I-NP O
( -LRB- I-NP O
3/74 NN I-NP B-DATE
) -RRB- I-NP O
: : O O
fixed VBN B-VP O
anterior/inferior JJ B-NP O
defects NNS I-NP O
and CC O O
no DT B-NP O
reversible JJ I-NP O
ischemia NN I-NP O
or CC I-NP O
EKG NN I-NP O
changes NNS I-NP O
5 CD B-NP O
. . O O
Renal NNP B-NP O
failure/Proteinuria VBD B-VP O
: : O O
longstanding JJ B-NP O
nephrotic JJ I-NP O
range NN I-NP O
proteinuria NN I-NP O
has VBZ B-VP O
persisted VBN I-VP O
despite IN B-PP O
ACE/ARB. NNP B-NP O
Raised NNPS I-NP O
concerns VBZ B-VP O
about IN B-PP O
alternate JJ B-NP O
process NN I-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
DN. NNP B-NP O
Was VBD B-VP O
biopsied VBN I-VP O
on IN B-PP O
11/27 CD B-NP B-DATE
--biopsy NN I-NP O
showed VBD B-VP O
nodular JJ B-NP O
diabetid NN I-NP O
glomerulosclerosis NN I-NP O
-- : B-NP O
Baseline NNP I-NP O
Cr NNP I-NP O
0.7 CD I-NP O
to TO B-PP O
0.9 CD B-NP O
6 CD B-NP O
. . O O
Traumatic NNP B-NP O
brain NN I-NP O
injury NN I-NP O
s/p DT B-NP O
MV NNP I-NP O
in IN B-PP O
9/2070 CD B-NP B-DATE
. . O O
7. DT B-NP O
H/O NNP I-NP O
L NNP I-NP O
Breast NNP I-NP O
cancer NN I-NP O
: : O O
00664 CD B-NP B-IDNUM
-- : O O
T2 DT B-NP O
N0 NNP I-NP O
MX NNP I-NP O
invasive JJ I-NP O
ductal NN I-NP O
carcinoma NN I-NP O
s/p NN I-NP O
lumpectomy NN I-NP O
, , O O
wide JJ B-NP O
excision NN I-NP O
, , O O
postop NN B-NP O
XRT CC O O
-- : O O
LVI-, JJ B-NP O
margins NNS I-NP O
-, , O O
ER+PR+ NNP B-NP O
, , O O
HER NNP B-NP O
2/neu- . O O
8. NN B-NP O
Left VBD B-VP O
carotid VBN I-VP O
endarderectomy NN B-NP O
9 CD B-LST O
. . O O
Left VBD B-VP O
upper JJ B-NP O
lobe NN I-NP O
lung NN I-NP O
nodule NN I-NP O
10 CD B-NP O
. . O O
Comminuted NNP B-NP O
impacted VBD B-VP O
R NN B-NP O
humerus NN I-NP O
surgical JJ I-NP O
neck NN I-NP O
fx NN I-NP O
s/p NN I-NP O
mechanical JJ I-NP O
fall NN I-NP O
on IN B-PP O
12/19 CD B-NP B-DATE
11 CD B-LST O
. . O O
Depression NN O O
12 CD B-LST O
. . O O
Anxiety '' O O
13 CD B-LST O
. . O O
Insomnia '' O O
14 CD B-LST O
. . O O
Onychomycosis '' O O
MEDICATIONS NNS B-NP O
ON IN B-PP O
ADMISSION NNP B-NP O
: : O O
1 CD B-NP O
. . O O
Acetaminophen NNP B-PP O
W/Codeine NNP B-NP O
30mg CD I-NP O
( -LRB- I-NP O
Tylenol NNP B-PP O
# # B-NP O
3 CD I-NP O
) -RRB- I-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
Q6H NNP I-NP O
prn NN I-NP O
2. . B-NP O
Magnesium NNP I-NP O
Hydroxide NNP I-NP O
( -LRB- I-NP O
Milk NN I-NP O
Of IN B-PP O
Magnesia NNP B-NP O
) -RRB- I-NP O
30 CD I-NP O
ML NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
prn NN I-NP O
constipation NN I-NP O
3. DT B-NP O
Bisacodyl NNP I-NP O
5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
prn NN I-NP O
constipation NN I-NP O
4 CD B-NP O
. . O O
Multivitamins NNP O O
( -LRB- O O
Mvi NNP B-NP O
) -RRB- I-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
QD . O O
5 CD B-NP O
. . O O
Docusate NNP B-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Colace NN I-NP O
) -RRB- I-NP O
200 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QD NNP I-NP O
prn NN I-NP O
constipation NN I-NP O
6 CD B-NP O
. . O O
Acetylsalicylic NNP B-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Asa NNP I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
7. CD B-NP O
Anastrozole NNP I-NP O
( -LRB- I-NP O
Arimidex NNP I-NP O
) -RRB- I-NP O
1 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
8. DT B-NP O
Atenololl NNP I-NP O
50 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
9 CD B-NP O
. . O O
Calcium NNP B-NP O
Carbonate NNP I-NP O
1250 CD I-NP O
Mg NNP I-NP O
( -LRB- I-NP O
500 CD I-NP O
Mg NNP I-NP O
Elem NNP I-NP O
Ca MD B-VP O
) -RRB- B-NP O
2 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
10 CD B-NP O
. . O O
Fluoxetine NNP B-NP O
Hcl NNP I-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
11 CD B-NP O
. . O O
Fosamax NNP O O
( -LRB- O O
Alendronate NNP B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QWEEK . O O
12 CD B-NP O
. . O O
Hydrochlorothiazide NNP O O
( -LRB- O O
Hctz NN B-NP O
) -RRB- I-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
13 CD B-NP O
. . O O
Lisinoprill NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
14 CD B-NP O
. . O O
Losartan NNP B-NP O
50 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
15 CD B-NP O
. . O O
Metformin NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
one CD I-NP O
tab NN I-NP O
qAM NN I-NP O
, , O O
1 CD B-NP O
qNOON NN I-NP O
, , O O
2 CD B-NP O
tabs NNS I-NP O
in IN B-PP O
evening NN B-NP O
. . O O
16 CD B-NP O
. . O O
Simvastatin NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS . O O
17 CD B-NP O
. . O O
Glipizide NNP B-PP O
( -LRB- B-NP O
Glucotrol NN I-NP O
) -RRB- I-NP O
5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
BEFORE NNP I-NP O
BREAKFAST NN I-NP O
AND CC O O
BEFORE VB B-VP O
SUPPER NN B-NP O
18 CD B-NP O
. . O O
Acetaminophen NNP B-NP O
650 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
prn NN I-NP O
19 CD B-NP O
. . O O
Lorazepam NNP B-NP O
1 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q12H . O O
ALLERGIES NNS B-NP O
: : O O
NKDA NNP B-NP O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Mother NN B-NP O
: : O O
CHF NN B-NP O
Father NNP B-NP O
: : O O
Prostate NNP B-NP O
and CC I-NP O
colon NN I-NP O
cancer NN I-NP O
Siblings NNS B-NP O
: : O O
none NN B-NP O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
The DT B-NP O
patient JJ I-NP O
lives NNS I-NP O
in IN B-PP O
Poinciana NNP B-NP B-CITY
alone RB B-ADVP O
but CC O O
has VBZ B-VP O
been VBN I-VP O
in IN B-PP O
rehab NN B-NP O
for IN B-PP O
her PRP$ B-NP O
humeral JJ I-NP O
fracture NN I-NP O
. . O O
She PRP B-NP O
plans VBZ B-VP O
to TO I-VP O
return VB I-VP O
home NN B-NP O
. . O O
5 CD B-NP O
sons NNS I-NP O
. . O O
Retired NNP B-NP O
Electrical NNP I-NP B-PROFESSION
Contractor NNP I-NP I-PROFESSION
Tobacco NNP B-NP O
: : O O
Quit VB B-VP O
1/8 CD B-NP I-DATE
/2075 CD I-NP I-DATE
. . O O
1PPD IN B-PP O
since IN I-PP O
teens NNS B-NP O
Alcohol NN B-NP O
: : O O
None NN B-NP O
Illicit NNP B-NP O
drugs NNS I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
denies VBZ B-VP O
past JJ B-ADJP O
and CC O O
present JJ B-NP O
use NN I-NP O
of IN B-PP O
illicit JJ B-NP O
drugs NNS I-NP O
. . O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
VITALS NNS B-NP O
: : O O
Tcurrent NN B-NP O
: : O O
97.3 CD B-NP O
HR NNP I-NP O
: : O O
62 CD B-NP O
BP NNP I-NP O
: : O O
155/67 CD B-NP O
RR NN I-NP O
: : O O
16 CD B-NP O
O2Sat JJ I-NP O
: : O O
92 CD B-NP O
% NN I-NP O
4L JJ B-NP O
NC NNP I-NP O
GEN&#8217;L NNP B-NP O
NAD NNP I-NP O
, , O O
Non-toxic JJ B-NP O
appearing VBG I-NP O
, , O O
AO NNP B-NP O
x NN I-NP O
3 CD O O
HEENT NNP B-NP O
NCAT. NNP I-NP O
PEERLA NNP I-NP O
. . I-NP O
EOMI NNP I-NP O
. . O O
NECK NNP B-NP O
Supple NNP I-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
or CC O O
LAD. NNP B-NP O
Carotids NNPS I-NP O
are VBP B-VP O
2+ JJ B-ADJP O
bilaterally RB B-ADVP O
without IN B-PP O
bruits NNS B-NP O
. . B-NP O
JVP NN I-NP O
10cm . O O
HEART NNP B-NP O
RRR NNP I-NP O
. . I-NP O
Normal NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . O O
No DT B-NP O
m/r/g NN I-NP O
LUNG NNP B-NP O
Rhonchi NNP I-NP O
and CC O O
crackles NNS B-NP O
at IN B-PP O
bases NNS B-NP O
bilat , O O
. . O O
No DT B-NP O
wheeze NN I-NP O
. . O O
BACK NNP B-NP O
Normal JJ I-NP O
spine NN I-NP O
curvature NN I-NP O
. . O O
No DT B-NP O
paraspinal JJ I-NP O
tenderness NN I-NP O
. . O O
No DT B-NP O
CVA NNP I-NP O
tenderness NN I-NP O
. . O O
ABD NNP B-NP O
: : O O
Soft NNP B-NP O
, , O O
non-tender JJ B-NP O
, , I-NP O
non-distended JJ I-NP O
. . I-NP O
Active NNP I-NP O
BS. . O O
EXT NNP B-NP O
WWP NNP I-NP O
distally RB B-ADVP O
. . O O
2+ JJ B-NP O
pitting VBG I-NP O
edema NN I-NP O
to TO B-PP O
thighs NNS B-NP O
. . O O
NEURO NNP B-NP O
: : O O
Alert NNP B-NP O
. . I-NP O
Oriented NNP I-NP O
to TO B-PP O
person NN B-NP O
, , I-NP O
place NN I-NP O
, , I-NP O
time NN I-NP O
. . O O
CN NNP B-NP O
II-XII NNP I-NP O
grossly RB I-NP O
intact JJ I-NP O
. . I-NP O
Sensation NNP I-NP O
grossly RB I-NP O
intact JJ I-NP O
to TO B-PP O
light JJ B-NP O
touch NN I-NP O
and CC I-NP O
vibration NN I-NP O
. . O O
CHEMISTRIES NNS B-NP O
21-Jan-2075 CD B-NP B-DATE
03 CD I-NP O
:59 . O O
Plasma NNP B-NP O
Sodium NNP I-NP O
136 CD O O
Plasma NNP B-NP O
Potassium NNP I-NP O
4.3 CD O O
Plasma NNP B-NP O
Chloride NNP I-NP O
98 CD I-NP O
L NNP I-NP O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
32.4 CD I-NP O
H NNP I-NP O
Calcium NNP B-NP O
9.4 CD I-NP O
Phosphorus NNP B-NP O
3.9 CD I-NP O
Magnesium NNP B-NP O
2.2 CD I-NP O
H NNP I-NP O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
20 CD O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
0.9 CD O O
Plasma NNP B-NP O
Glucose NNP I-NP O
297 CD I-NP O
H NNP I-NP O
NT-proBNP NNP B-NP O
8924 CD I-NP O
H NNP B-NP O
3900 CD I-NP O
in IN B-PP O
3/2074 CD B-NP B-DATE
CARDIAC NNP B-NP O
ENZYMES NNP I-NP O
21-Jan-2075 CD B-NP B-DATE
04:33 CD I-NP O
and CC I-NP O
11:00 CD I-NP O
AM VBP I-NP O
Creatine JJ B-NP O
Kinase NNP I-NP O
Isoenzymes NNP I-NP O
NEGATIVE JJ I-NP O
x2 NN I-NP O
at IN B-PP O
4AM CD B-NP O
and CC I-NP O
11AM CD I-NP O
Troponin-I NNP B-NP O
NEGATIVE JJ I-NP O
X2 NNP I-NP O
at IN B-PP O
4AM CD B-NP O
and CC I-NP O
11AM CD I-NP O
HEMATOLOGY NN B-NP O
21-Jan-2075 CD B-NP B-DATE
03 CD I-NP O
:59 . O O
WBC NNP B-NP O
21.3 CD I-NP O
H NNP I-NP O
HCT NNP B-NP O
41.9 CD I-NP O
HGB NNP B-NP O
13.0 CD I-NP O
RBC NNP B-NP O
4.36 CD I-NP O
PLT NNP B-NP O
659 CD I-NP O
H NNP I-NP O
MCV RB B-NP O
96 CD I-NP O
MCH NNP B-NP O
29.9 CD I-NP O
MCHC NNP B-NP O
31.1 CD I-NP O
RDW NNP B-NP O
12.6 CD I-NP O
Superstat NNP B-NP O
PT NNP I-NP O
11.7 CD O O
Superstat NNP B-NP O
PT-INR NNP I-NP O
1.0 CD O O
Superstat NNP B-NP O
APTT NNP I-NP O
24.4 CD O O
Diff JJ B-NP O
Method NNP I-NP O
Auto NN I-NP O
Poly NNP B-NP O
80 CD I-NP O
H NNP I-NP O
Lymphs NNP B-NP O
13 CD I-NP O
L NNP I-NP O
Monos NNP B-NP O
4 CD I-NP O
EOS NNP B-NP O
2 CD I-NP O
Basos NNS B-NP O
1 CD B-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
16.96 CD I-NP O
H NNP I-NP O
Absolute JJ B-NP O
Lymphs NNP I-NP O
2.83 CD O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.89 CD I-NP O
H NNP I-NP O
Absolute JJ B-NP O
EOS NNP I-NP O
0.48 CD I-NP O
H NNP I-NP O
Absolute JJ B-NP O
Basos NNP I-NP O
0.12 CD O O
Aniso NNP B-NP O
None NN I-NP O
Hypo NNP B-NP O
1+ CD I-NP O
H NNP I-NP O
Macrocytes NNP B-NP O
None NN I-NP O
Microcytes NNS B-NP O
None NN I-NP O
URINALYSIS . O O
21-Jan-2075 CD B-NP B-DATE
05:37 CD I-NP O
UA-Color NNP B-NP O
Yellow NNP I-NP O
UA-Turbidity NNP B-NP O
Clear NNP I-NP O
UA-Specific JJ B-NP O
Gravity NNP I-NP O
1.020 CD O O
UA-pH NNP B-NP O
7.0 CD I-NP O
UA-WBC JJ B-NP O
Screen NNP I-NP O
NEGATIVE CD O O
UA-Nitrite JJ B-NP O
NEGATIVE JJ I-NP O
UA-Glucose JJ B-NP O
Trace NN I-NP O
UA-Ketones NNP B-NP O
NEGATIVE CD I-NP O
Urobilinogen NN B-NP O
NEGATIVE JJ I-NP O
Bili NNP B-NP O
NEGATIVE CD I-NP O
UA-Occult JJ B-NP O
Blood NN I-NP O
2+ . O O
UA-SED-RBC NNP B-NP O
20-50 CD I-NP O
UA-SED-WBC NNP B-NP O
0-2 CD I-NP O
UA-SED-Bacteria NNP B-NP O
NEGATIVE CD I-NP O
Hyaline NNP B-NP O
Cast NNP I-NP O
3-5 CD O O
Squamous JJ B-NP O
Cells NNP I-NP O
NEGATIVE CD O O
UA-Albumin NNP B-NP O
3+ CD I-NP O
MICROBIOLOGY NNP B-NP O
: : O O
None NN B-NP O
RADIOLOGY NN B-NP O
1 LS O O
. . B-NP O
CXR NNP I-NP O
: : O O
Lungs NNP B-NP O
: : O O
The DT B-NP O
lungs NNS I-NP O
are VBP B-VP O
satisfactorily RB I-VP O
inflated VBN I-VP O
. . O O
There EX B-NP O
is VBZ B-VP O
increasing VBG I-VP O
prominence NN B-NP O
of IN B-PP O
the DT B-NP O
interstitium NN I-NP O
and CC I-NP O
peribronchial JJ I-NP O
cuffing NN I-NP O
when WRB B-ADVP O
compared VBN B-VP O
to TO B-PP O
the DT B-NP O
prior JJ I-NP O
study NN I-NP O
consistent JJ B-ADJP O
with IN B-PP O
interval NN B-NP O
development NN I-NP O
of IN B-PP O
CHF. NNP B-NP O
Surgical NNP I-NP O
clips NNS I-NP O
are VBP B-VP O
again RB I-VP O
noted VBN I-VP O
projected VBN I-VP O
over IN B-PP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
hemithorax NN I-NP O
. . O O
No DT B-NP O
definite JJ I-NP O
focal JJ I-NP O
consolidation NN I-NP O
is VBZ B-VP O
demonstrated VBN I-VP O
. . B-NP O
Pleura NNP I-NP O
: : O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
pneumothorax NN I-NP O
. . O O
The DT B-NP O
hemidiaphragms NNS I-NP O
are VBP B-VP O
very RB B-ADVP O
slightly RB I-ADVP O
less RBR B-ADJP O
distinct JJ I-ADJP O
than IN B-PP O
on IN B-PP O
the DT B-NP O
comparison NN I-NP O
study NN I-NP O
. . O O
This DT B-NP O
could MD B-VP O
be VB I-VP O
related VBN I-VP O
to TO B-PP O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
parenchymal JJ B-NP O
changes NNS I-NP O
of IN B-PP O
CHF NNP B-NP O
, , O O
but CC O O
could MD B-VP O
also RB I-VP O
be VB I-VP O
related VBN I-VP O
to TO B-PP O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-PP O
pleural JJ B-NP O
fluid NN I-NP O
. . B-NP O
IMPRESSION NN I-NP O
: : O O
Findings NNP B-NP O
consistent JJ I-NP O
with IN B-PP O
CHF. NNP B-NP O
2. . B-NP O
Bilateral NNP I-NP O
LENIs NNP I-NP O
: : O O
NO DT B-NP O
EVIDENCE NN I-NP O
OF IN B-PP O
FEMORAL NNP B-NP O
OR JJ I-NP O
POPLITEAL NNP I-NP O
DEEP NNP I-NP O
VENOUS NNP I-NP O
THROMBOSIS NNPS I-NP O
OF IN B-PP O
EITHER NNP B-NP O
LEG. NNP I-NP O
EKG NNP B-NP O
: : O O
Normal JJ B-ADJP O
sinus IN B-PP O
rhythm NN B-NP O
at IN B-PP O
95 CD B-NP O
. . O O
Normal JJ B-NP O
axis NN I-NP O
. . O O
Normal JJ B-NP O
PR NNP I-NP O
, , O O
QRS NNP B-NP O
, , O O
QT NNP B-NP O
intervals NNS I-NP O
. . O O
No DT B-NP O
ST NNP I-NP O
elevations NNS I-NP O
or CC I-NP O
depressions NNS I-NP O
. . O O
? . O O
Q NNP B-NP O
waves NNS I-NP O
in IN B-PP O
v1 CD B-NP O
, , I-NP O
v2 CD I-NP O
, , I-NP O
v3 CD I-NP O
but CC I-NP O
also RB B-ADVP O
may MD B-VP O
be VB I-VP O
upslopes NNS B-NP O
before IN B-PP O
the DT B-NP O
downslops NNS I-NP O
. . O O
However RB B-ADJP O
new JJ I-ADJP O
since IN B-PP O
12/12/2074 CD O B-DATE
ASSESSMENT NNP B-NP O
&amp; NNP I-NP O
PLAN NNP I-NP O
Mrs. NNP B-NP O
Ito NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
69 CD I-NP B-AGE
F NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
CHF NNP B-NP O
( -LRB- O O
EF NNP B-NP O
40 CD I-NP O
% NN I-NP O
, , O O
no DT B-NP O
home NN I-NP O
O2 IN B-PP O
) -RRB- B-NP O
, , O O
DM NNP B-NP O
type NN I-NP O
2 CD B-NP O
, , O O
HTN NNP B-NP O
, , O O
nephritic JJ B-NP O
syndrome NN I-NP O
, , O O
and CC O O
1/15/2075 CD B-NP B-DATE
R NN I-NP O
humerus NN I-NP O
ORIF IN B-PP O
presenting VBG B-VP O
from IN B-PP O
Crest NNP B-NP B-HOSPITAL
Nursing NNP I-NP I-HOSPITAL
Home NNP I-NP I-HOSPITAL
with IN B-PP O
SOB NNP B-NP O
and CC I-NP O
HTN. NNP I-NP O
Her PRP$ B-NP O
exam NN I-NP O
and CC I-NP O
imaging NN I-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
, , O O
as IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
. . O O
The DT B-NP O
precipitant NN I-NP O
of IN B-PP O
her PRP$ B-NP O
flash NN I-NP O
pulmonary NN I-NP O
edema NN I-NP O
is VBZ B-VP O
less RBR B-ADJP O
clear JJ I-ADJP O
, , O O
however RB B-ADVP O
. . O O
She PRP B-NP O
describes VBZ B-VP O
waking VBG I-VP O
up IN B-PRT O
acutely RB B-NP O
short JJ I-NP O
of IN B-PP O
breath NN B-NP O
and CC O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
profoundly RB B-ADJP O
hypertensive JJ I-ADJP O
. . O O
It PRP B-NP O
is VBZ B-VP O
possible JJ B-ADJP O
that IN B-SBAR O
HTN NNP B-NP O
2/2 VBD B-VP O
a DT B-NP O
change NN I-NP O
in IN B-PP O
her PRP$ B-NP O
diet NN I-NP O
or CC I-NP O
fluid NN I-NP O
intake NN I-NP O
at IN B-PP O
rehab NN B-NP O
, , O O
ischemia NN B-NP O
, , O O
increases NNS B-NP O
renin-aldo NN I-NP O
, , O O
or CC O O
other JJ B-NP O
cause NN I-NP O
led VBD B-VP O
to TO I-VP O
flash VB I-VP O
pulmonary JJ B-NP O
edema NN I-NP O
. . O O
Conversely RB B-ADVP O
, , O O
however RB B-ADVP O
, , O O
CHF NNP B-NP O
may MD B-VP O
have VB I-VP O
precipitated VBN I-VP O
her PRP B-NP O
HTN. . O O
1 LS O O
. . O O
Shortness NNP O O
of IN B-PP O
breath/CHF NN B-NP O
: : O O
Evidence NN B-NP O
of IN B-PP O
volume NN B-NP O
overload NN I-NP O
by IN B-PP O
exam NN B-NP O
and CC I-NP O
imaging NN I-NP O
. . O O
PE NN B-VP O
also RB B-ADVP O
on IN B-PP O
the DT B-NP O
differential JJ I-NP O
but CC O O
seems VBZ B-VP O
less RBR B-ADJP O
likely JJ I-ADJP O
given VBN B-PP O
improvement NN B-NP O
of IN B-PP O
resp NN B-NP O
status NN I-NP O
, , O O
negative JJ B-NP O
LENIs NNS I-NP O
. . O O
-- : O O
Lasix NNP B-NP O
40mg CD I-NP O
IV NNP I-NP O
now RB I-NP O
-- : B-NP O
Strict NNP I-NP O
I+O NNP I-NP O
-- : O O
Daily NNP B-NP O
weights NNS I-NP O
-- : B-NP O
F/up NNP I-NP O
PA/Lat NNP I-NP O
-- : B-NP O
Continuous NNP I-NP O
O2 NNP I-NP O
sat VBD B-VP O
monitor;Telemetry NN B-NP O
, , O O
cardiac JJ B-NP O
monitor NN I-NP O
-- : O O
f/up NN B-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
-- : O O
ASA NNP B-NP O
325 CD I-NP O
qd . O O
-- : O O
Will MD B-VP O
give VB I-VP O
Lopressor NNP B-NP O
25 CD I-NP O
Q8 . O O
and CC O O
Captopril NNP B-NP O
50 CD I-NP O
Q8 NNS I-NP O
for IN B-PP O
now RB B-NP O
but CC O O
may MD B-VP O
need VB I-VP O
to TO B-VP O
reconsider VB I-VP O
the DT B-NP O
BB NNP I-NP O
if IN B-PP O
CHF NNP B-NP O
less RBR I-NP O
compensated VBN B-VP O
. . O O
-- : O O
Albuterol NNP B-NP O
and CC I-NP O
atrovent NN I-NP O
for IN B-PP O
possible JJ B-NP O
COPD NNP I-NP O
component NN I-NP O
given VBN I-NP O
tobacco NN I-NP O
history NN I-NP O
-- : O O
Consider VB B-VP O
TTE NNP B-NP O
in IN B-ADVP O
AM VBP O O
-- : O O
Consider VB B-VP O
PFTs NNS B-NP O
2. DT B-NP O
Leukocytosis NNP I-NP O
: : O O
Infection NN B-NP O
vs JJ I-NP O
stress NN I-NP O
response NN I-NP O
. . O O
Patient NNP B-NP O
presents NNS I-NP O
with IN B-PP O
elevated JJ B-NP O
WBC NNP I-NP O
with IN B-PP O
80 CD B-NP O
% NN I-NP O
polys NNS I-NP O
. . O O
Infectious NNP B-NP O
work-up NN I-NP O
has VBZ B-VP O
included VBN I-VP O
U/A NNP B-NP O
that WDT B-NP O
is VBZ B-VP O
negative JJ B-ADJP O
for IN B-PP O
infection NN B-NP O
. . O O
CXR NN B-NP O
does VBZ B-VP O
not RB I-VP O
show VB I-VP O
evidence NN B-NP O
of IN B-PP O
focal JJ B-NP O
consolidation NN I-NP O
, , O O
however RB B-ADVP O
may MD B-VP O
be VB I-VP O
obscured VBN I-VP O
by IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
. . O O
Mental JJ B-NP O
status NN I-NP O
at IN B-PP O
baseline NN B-NP O
. . O O
I PRP B-NP O
am VBP B-VP O
suspicious JJ B-ADJP O
for IN B-PP O
PNA NNP B-NP O
given VBN B-VP O
her PRP$ B-NP O
report NN I-NP O
of IN B-PP O
productive JJ B-NP O
cough NN I-NP O
howeve NN I-NP O
do VBP B-VP O
not RB I-VP O
feel VB I-VP O
pressed VBN I-VP O
to TO B-VP O
treat VB I-VP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
as IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
afeb. VBG I-VP O
-- : O O
Cont NNP B-NP O
to TO B-VP O
follow VB I-VP O
fever NN B-NP O
curve NN I-NP O
and CC O O
WBC NNP B-NP O
-- : B-NP O
F/up NNP I-NP O
PA/Lat NNP I-NP O
-- : O O
Consider VB B-VP O
addition NN B-NP O
of IN B-PP O
abx NN B-NP O
for IN B-PP O
HAP NNP B-NP O
if IN B-PP O
fever NN B-NP O
, , O O
PA/lat NNP B-NP O
concerning VBG I-NP O
-- : O O
F/up IN B-PP O
Blood NN B-NP O
cultures NNS I-NP O
and CC O O
sputum JJ B-NP O
cultures NNS I-NP O
-- : O O
F/up IN B-PP O
c NN B-NP O
diff NN I-NP O
3. CD B-NP O
Hypertension NNP I-NP O
: : O O
Home NNP B-NP O
HTN NNP I-NP O
regimen NNP I-NP O
is VBZ B-VP O
Atenolol NNP B-NP O
50mg CD I-NP O
QD NNP I-NP O
, , I-NP O
HCTZ NNP I-NP O
25 CD I-NP O
qday NN I-NP O
, , O O
Lisinopril NNP B-NP O
40 CD I-NP O
qday NN I-NP O
, , O O
Losartan NNP B-NP O
50 CD I-NP O
BID NNS I-NP O
-- : B-NP O
Start NNP I-NP O
Captoril NNP I-NP O
50 CD I-NP O
mg NN I-NP O
Q8 CD I-NP O
and CC O O
Lopressor NNP B-NP O
25 CD I-NP O
q8 CD I-NP O
and CC O O
titrate VB B-VP O
up RP B-PRT O
as IN B-NP O
needed VBN B-VP O
fo VB I-VP O
tight JJ B-NP O
BP NNP I-NP O
control NN I-NP O
-- : O O
Cardiac NNP B-NP O
monitor NN I-NP O
4 CD B-LST O
. . O O
DM NNP B-NP O
type NN I-NP O
2 CD I-NP O
: : O O
Home NNP B-NP O
regimen NNP I-NP O
is VBZ B-VP O
Metformin/Glucotrol NNP B-NP O
. . O O
-- : O O
D/c JJ B-NP O
oral JJ I-NP O
agents NNS I-NP O
and CC O O
start VB B-VP O
Insulin NNP B-NP O
SS NNP I-NP O
w VBD B-VP O
BID NNP B-NP O
BS NNP I-NP O
5 CD B-NP O
. . O O
Hematuria/Proteinuria NNP O O
on IN B-PP O
U/A NNP B-NP O
: : O O
Consisent VB B-VP O
with IN B-ADVP O
prior RB I-ADVP O
U/A . O O
6 CD B-NP O
. . O O
Breast NNP B-NP O
CA NNP I-NP O
: : O O
Cont NNP B-NP O
Arimidex FW I-NP O
( -LRB- I-NP O
hormone NN I-NP O
tx NN I-NP O
) -RRB- O O
7. DT B-NP O
HL NNP I-NP O
: : O O
Cont NNP B-NP O
statin NN I-NP O
8. DT B-NP O
Depression NNP I-NP O
: : O O
Cont NNP B-NP O
Prozac NNP I-NP O
9 CD B-NP O
. . I-NP O
Tobacco NNP I-NP O
use NN I-NP O
: : O O
Cont NNP B-NP O
Chantix NNP I-NP O
0.5 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QDay NN I-NP O
10 CD B-NP O
. . O O
Anxiety NNP B-NP O
: : O O
Ativan NNP B-VP O
PRN NNP B-NP O
at IN B-PP O
home NN B-NP O
. . O O
11 CD B-NP O
. . O O
FEN NNP B-NP O
: : O O
Low NNP B-NP O
chol NN I-NP O
, , O O
low JJ B-NP O
sat VBD B-VP O
fat JJ B-ADJP O
, , O O
ADA NNP B-NP O
diet NN I-NP O
with IN B-PP O
no DT B-NP O
added JJ I-NP O
salt NN I-NP O
. . B-VP O
Cont NNP B-NP O
Vit NNP I-NP O
D/ NNP I-NP O
Calcium NNP I-NP O
12 CD B-LST O
. . O O
PROPHYLAXIS NNPS B-ADVP O
: : O O
GI NNP B-NP O
: : O O
Not RB B-VP O
indicated VBN I-VP O
DVT NNP B-NP O
: : O O
Heparin NNP B-NP O
5000 CD B-NP O
Units NNS I-NP O
SC VBP B-VP O
BID NNP B-NP O
BOWEL NNP I-NP O
: : O O
Colace/Senna NNP B-NP O
PRN NNP I-NP O
13 CD B-NP O
. . O O
CODE NNP B-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
Code NNP I-NP O
( -LRB- B-VP O
Discussed VBN I-VP O
with IN B-PP O
patient NN B-NP O
) -RRB- O O
Jocelyn NNP B-NP B-DOCTOR
T NNP I-NP I-DOCTOR
Issa NNP I-NP I-DOCTOR
MD NNP I-NP O
, , O O
Mphil NNP B-NP O
Pager NNP B-NP O
# # I-NP O
61158 CD O B-PHONE
